Technology | May 04, 2009

UltraSPECT Introduces the Xpress3.Cardiac Image Reconstruction in U.S.

May 4, 2009 –UltraSPECT said April 30 it intends to offer the Xpress3.Cardiac SPECT WBR-based SPECT image reconstruction package for sale in the U.S., which the company said enables short acquisition times with good resolution.

The Xpress3.Cardiac reportedly enables short scan times without compromising image quality and diagnostic confidence. The company said the scan times are three minutes for stress and less than five minutes for rest. The Xpress3.Cardiac was FDA cleared in May of 2008 and was showcased at the ASNC 2008 Annual Meeting last September in Boston. The product has since been in routine clinical use at a limited number of sites in the U.S. and Europe, including St. Luke's Roosevelt Hospital in New York City, Mayo Clinic, Duke University Medical Center, Baptist Hospital of Miami, and Atlanta Heart Specialists.

The Xpress3.Cardiac is fully automatic, with a single processing protocol for all patients. The hardware platform is based on a quad-core CPU, which can be connected to the gamma camera and workstation network in a matter of hours. The company said this enables quarter-time image acquisition with reconstructions that are the same or better than using standard imaging times. UltraSPECT said there is no extra work required of the technologist, as the image reconstruction process is completely transparent to the department's clinical workflow.

The Xpress3.Cardiac, along with UltraSPECT’s Xpress.Cardiac and Xpress/Xact.Bone products, are exclusively distributed in the U.S. by Cardinal Health.

For more information: www.ultraspect.com

Related Content

A PET/CT head and neck cancer scan.

A PET/CT head and neck cancer scan.

Feature | Nuclear Imaging | November 05, 2018 | By Sabyasachi Ghosh
“Experimental validation implemented in real-life situations and not theoretical claims exaggerating small advantages
Technology and Radionucleotide Development Will Fuel Mobile Gamma Camera Adoption
News | Nuclear Imaging | September 27, 2018
Advancements in healthcare technology, particularly in the surgery category, have led to an increasing adoption of...
Brain Study of 62,454 Scans Identifies Drives of Brain Aging
News | SPECT Imaging | August 27, 2018
In the largest known brain imaging study, scientists from five institutions evaluated 62,454 brain single photon...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
MILabs Introduces Futuristic PET Capabilities on New VECTor6 System
Technology | PET Imaging | June 28, 2018
At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, June 23-26, in Philadelphia,...
New ASNC SPECT Imaging Guideline Addresses Advances in Myocardial Perfusion Imaging
News | SPECT Imaging | June 21, 2018
The American Society of Nuclear Cardiology (ASNC) has published an update to its 2010 guidelines for single photon...
News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
The Chalk River nuclear reactor license has been renewed, but will be decommissioned by 2028.

The Chalk River nuclear isotope reactor license has been renewed, but will be decommissioned by 2028. The reactor supplies about 50 percent of the world's supply of Tc99m.

Feature | Nuclear Imaging | April 02, 2018 | Dave Fornell
April 2, 2018 – The Canadian Nuclear Safety Commission (CNSC) announced March 29 that it renewed Canadian Nuclear Lab
A Tc99m SPECT cardiac exam showing myocardial perfusion in the heart.

Technetium-99m is primarily used for the detection of cancer and to assess perfusion defects in the heart caused by heart attacks or other conditions.

Feature | Radiopharmaceuticals and Tracers | February 08, 2018 | Dave Fornell
February 8, 2018 — The U.S.